Soluble interleukin 2 receptor and neopterin serum levels after lung/heart-lung transplantations--absence of predictive value for late allograft rejection.
Humbert
M
M
INSERM U131, Clamart, France.
Emilie
D
D
Cerrina
J
J
Simonneau
G
G
Rain
B
B
Fattal
S
S
Le Roy Ladurie
F
F
Dartevelle
P
P
Duroux
P
P
Galanaud
P
P
D000293:Adolescent; D000328:Adult; D001708:Biopterins / Q000031:analogs & derivatives* / Q000097:blood; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D001999:Bronchoscopy / Q000379:methods; D002648:Child; D005260:Female; D005336:Fiber Optic Technology; D006084:Graft Rejection; D016041:Heart-Lung Transplantation / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016040:Lung Transplantation / Q000009:adverse effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D011237:Predictive Value of Tests; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D001708:Biopterins; D019798:Neopterin